| Health / Medical Topics |
Ruthenium-based Transferrin Targeting Agent NKP-1339
A ruthenium-containing cancer agent targeting transferrin with potential antineoplastic activity. Upon intravenous administration, NKP-1339 (Ru3+) binds to transferrin (Tf) and is taken up via Tf receptors (TfR), which are overexpressed on cancer cells. Once inside the cell, NKP-1339 is released from Tf and is reduced, within the acidic environment of the endosomes, to its active form NKP-119 (Ru2+). In turn, the active form induces a redox reaction, thereby leading to the formation of reactive oxygen species (ROS) which inhibits GRP78 and SOD, endoplasmic reticulum-stress modulating molecules as well as BAG4 and ERK, program cell death regulating molecules. This eventually induces caspase-dependent apoptosis. (NCI Thesaurus)
YOU MAY ALSO LIKE
A radioactive isotope of the rare element ruthenium, a member of the light platinum group. A radioactive plaque containing ruthenium 106 may…
The essential oil extracted from the petals of Ruta graveolens. Ruta graveolens flower oil is used for relief of minor aches and…
A country in northern Asia , bordering the Arctic Ocean, between Europe and the North Pacific Ocean.
Denotes the inhabitants of Russia, a person from there, or their descendants elsewhere.
A code from a classification scheme that distinguishes metropolitan counties by the population size of their metro area, and nonmetropolitan counties by…
Populations living away from the congestion of city or suburb.
